Astera Labs (ALAB) EBITDA (2023 - 2026)

Astera Labs (ALAB) has 4 years of EBITDA data on file, last reported at $75.2 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 125.07% year-over-year to $75.2 million; the trailing twelve-month figure through Mar 2026 stood at $264.8 million (up 509.05% YoY), and the FY2025 full-year result was $223.0 million, up 367.88% from the prior year.
• EBITDA for Q1 2026 stood at $75.2 million, up from $45.2 million in the prior quarter.
• Across five years, EBITDA topped out at $92.3 million in Q3 2025 and bottomed at -$93.3 million in Q1 2024.
• A 4-year average of $14.6 million and a median of $14.9 million in 2023 frame the typical range for EBITDA.
• Across the five-year window, EBITDA tumbled 441.07% in 2024 and soared 3384.85% in 2025, its largest moves.
• Tracing ALAB's EBITDA over 4 years: stood at $14.9 million in 2023, then soared by 39.0% to $20.7 million in 2024, then soared by 118.24% to $45.2 million in 2025, then soared by 66.43% to $75.2 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $75.2 million, $45.2 million, and $92.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison